The invention relates to compounds of the general formula (and pharmaceutically acceptable derivatives thereof): ##STR1## in which RA, RB, RC, RD, R5, R7, R9, R9a, AK, p, q, r and X are as defined herein, and to their preparation and use.
The invention relates to compounds of the general formula (and pharmaceutically acceptable derivatives thereof): ##STR1##
in which RA, RB, RC, RD, R5, R7, R9, R9a, AK, p, q, r and X are as defined herein, and to their preparation and use.
Web www.patentalert.com
< Ribozyme mediated inactivation of the androgen receptor
< Modulators of leukocyte activation, Hck compositions and methods of use
> Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
> Method for the production and purification of adenoviral vectors
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT
